Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Other financing activities (2018 - 2022)

Editas Medicine (EDIT) has disclosed Other financing activities for 5 consecutive years, with $367000.0 as the latest value for Q2 2022.

  • Quarterly Other financing activities fell 30.23% to $367000.0 in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Jun 2022, changed 0.33% year-over-year, with the annual reading at $979000.0 for FY2022, 15.02% down from the prior year.
  • Other financing activities for Q2 2022 was $367000.0 at Editas Medicine, down from $526000.0 in the prior quarter.
  • The five-year high for Other financing activities was $526000.0 in Q2 2021, with the low at $100000.0 in Q1 2018.
  • Average Other financing activities over 5 years is $331333.3, with a median of $356000.0 recorded in 2018.
  • The sharpest move saw Other financing activities surged 50.29% in 2021, then plummeted 30.23% in 2022.
  • Over 5 years, Other financing activities stood at $362000.0 in 2018, then fell by 21.82% to $283000.0 in 2019, then grew by 23.67% to $350000.0 in 2020, then soared by 50.29% to $526000.0 in 2021, then tumbled by 30.23% to $367000.0 in 2022.
  • According to Business Quant data, Other financing activities over the past three periods came in at $367000.0, $526000.0, and $350000.0 for Q2 2022, Q2 2021, and Q2 2020 respectively.